tiprankstipranks
Mangoceuticals, Inc. (MGRX)
NASDAQ:MGRX
US Market
MGRX
Mangoceuticals, Inc.
RESEARCH TOOLSreports
Want to see MGRX full AI Analyst Report?

Mangoceuticals, Inc. (MGRX) Income Statement

157 Followers

Mangoceuticals, Inc. Income Statement

Last quarter (Q4 2025), Mangoceuticals, Inc.'s total revenue was $94.36K, a decrease of -10.34% from the same quarter last year. In Q4, Mangoceuticals, Inc.'s net income was $-2.77M. See Mangoceuticals, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 456.02K$ 615.87K$ 731.49K$ 8.94K$ 0.00
Gross Profit
$ 250.39K$ 379.96K$ 431.50K$ 4.85K$ 0.00
Operating Expenses
$ 19.41M$ 8.35M$ 9.65M$ 2.00M$ 17.52K
Depreciation and Amortization
$ 1.72M$ 721.53K$ 24.89K$ 3.86K$ 0.00
EBITDA
$ -18.82M$ -7.96M$ -8.09M$ -1.99M$ -17.52K
Operating Income
$ -19.15M$ -7.97M$ -9.22M$ -1.99M$ -17.52K
Other Income/Expenses
$ -1.49M$ -735.00K$ 6.47K$ -6.47K$ -181.00
Pretax Income
$ -20.64M$ -8.71M$ -9.21M$ -2.00M$ -17.70K
Net Income
$ -20.64M$ -8.71M$ -9.21M$ -2.00M$ -17.70K
Per Share Metrics
Basic EPS
$ -2.05$ -4.40$ -8.58$ -1.73$ -0.02
Diluted EPS
$ -2.05$ -4.40$ -8.58$ -1.73$ -0.02
Weighted Average Shares Outstanding
 10.07M 1.98M 1.07M 1.15M 997.67K
Weighted Average Shares Outstanding (Diluted)
 10.07M 1.98M 1.07M 1.15M 997.67K
Currency in USD

Mangoceuticals, Inc. Earnings and Revenue History